From a public policy perspective, how publicly funded medical research gets privatized by the award of patents is a critical issue. It leads to a loss of welfare for the poor people throughout the world and more so in the developing world. This raises issues related to health care provisioning and financing—namely public versus private intervention debate—accessibility and affordability issues, lack of medical researcher’s attention to the diseases pertaining to the poor only, geopolitical issues between the developed world and the developing world with regards to TRIPS among a host of other issues. In this article, it is shown how power and politics operate along dimensions of poor–rich, developed–developing world, public–private–NGOs and international agencies to keep the idea of IPRs as a critical instrument for health innovation alive.
Bachrach, P., & Baratz, M. S. (1975). Power and its two faces revisited: A reply to Geoffrey Debnam. The American Political Science Review, 69(3), 900–904.
Briesacher, B. A., Ross-Degnan, D., Wagner, A. K., Fouayzi, H., Zhang, F., Gurwitz, J. H., & Soumerai, S. B. (2010). Out-of-pocket burden of health care spending and the adequacy of the Medicare Part D low-income subsidy. Medical Care, 48(6), 503.
Ebi, K. L., & Semenza, J. C. (2008). Community-based adaptation to the health impacts of climate change. American Journal of Preventive Medicine, 35(5), 501–507.
8.
Foucault, M. (1982). The subject and power. Critical Inquiry, 8(4), 777–795.
9.
Haines, A., Kovats, R. S., Campbell-Lendrum, D., & Corvalán, C. (2006). Climate change and human health: Impacts, vulnerability and public health. Public Health, 120(7), 585–596.
Henry, C., & Stiglitz, J. E. (2010). Intellectual property, dissemination of innovation and sustainable development. Global Policy, 1(3), 237–251.
12.
Hillman, A. J., Withers, M. C., & Collins, B. J. (2009). Resource dependence theory: A review. Journal of Management, 35(6), 1404–1427.
13.
Kent, M. (2002). Reduction of catastrophic health care expenditures by a community-based health insurance scheme in Gujarat, India: Current experiences and challenges. Bulletin of the World Health Organization, 80(8), 613–621. Retrieved from http://www.who.int/bulletin/archives/en/80(8)613.pdf
Kunkel, K. E., PielkeJr., R. A., & Changnon, S. A. (1999). Temporal fluctuations in weather and climate extremes that cause economic and human health impacts: A review. Bulletin of the American Meteorological Society, 80(6), 077–1098.
16.
Leone, T., James, K. S., & Padmadas, S. S. (2012). The burden of maternal health care expenditure in India: Multilevel analysis of national data. Maternal and Child Health Journal, 17(9), 1622–1630.
17.
Love, J., & Hubbard, T. (2007). The bid idea: Prizes to stimulate R&D for new medicines. Chicago-Kent Law Review, 82(3), 1519.
18.
Lukes, S. (1974). Power: A radical view (Vol. 1). London: Macmillan.
19.
McCarthy, J. J., Canziani, O. F., Leary, N. A., Dokken, D. J., & White, K. S. (Eds.). (2001). Climate change 2001: impacts, adaptation, and vulnerability: contribution of Working Group II to the third assessment report of the Intergovernmental Panel on Climate Change (Vol. 2). UK: Cambridge University Press.
20.
Patz, J. A., Campbell-Lendrum, D., Holloway, T., & Foley, J. A. (2005). Impact of regional climate change on human health. Nature, 438(7066), 310–317.
21.
Patz, J. A., Epstein, P. R., Burke, T. A., & Balbus, J. M. (1996). Global climate change and emerging infectious diseases. JAMA: The Journal of the American Medical, 275(3), 217–223.
22.
Paul, S. (1992). Accountability in public services: Exit, voice and control. World Development, 20(7), 1047–1060.
23.
Polsby, N. W. (1970). The institutionalization of the US House of Representatives. American Political Science Review, 62(1), 144–168.
Stiglitz, J. (2002). Globalism’s discontents. The American Prospect, 13(1), A16–A21.
26.
Stiglitz, J. (2004). Towards a pro-development and balance intellectual property regime. Columbia University Draft.
27.
Stiglitz, J. (2006). Scrooge and intellectual property rights. BMJ: British Medical Journal, 333(7582), 1279.
28.
Stiglitz, J. (2007). Economic foundations of intellectual property rights. Duke Law Journal, 57(6), 1693.
29.
Stiglitz, J. (2008). Making globalisation work: The 2006 geary lecture. The Economic and Social Review, 39(3), 171–190.
30.
Stiglitz, J. E., & Jayadev, A. (2010). Medicine for tomorrow: Some alternative proposals to promote socially beneficial research and development in pharmaceuticals. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector, 7(3), 217–226.
Viana, J. (2001). Intellectual property rights, the World Trade Organization and public health: The Brazilian perspective. Connecticut Journal of International Law, 17(2), 311.
35.
Williams, O. D. (2012). Access to medicines, market failure and market intervention: A tale of two regimes. Global Public Health, 7(Suppl 2), S127–S143.
